EP Patent

EP1306095A3 — Methods and compositions for targeting the vasculature of solid tumors

Assigned to University of Texas System · Expires 2003-06-25 · 23y expired

What this patent protects

The invention relates generally to methods and compositions for targeting the vasculature of solid tumors using immunologically-based reagents. In particular aspects, immunological binding agents carrying selected diagnostic or therapeutic agents are targeted to the vasculature o…

USPTO Abstract

The invention relates generally to methods and compositions for targeting the vasculature of solid tumors using immunologically-based reagents. In particular aspects, immunological binding agents carrying selected diagnostic or therapeutic agents are targeted to the vasculature of solid tumor masses by binding to a marker expressed, accessible to binding or localized on intratumoral blood vessels of a vascularized tumor.

Drugs covered by this patent

Patent Metadata

Patent number
EP1306095A3
Jurisdiction
EP
Classification
—
Expires
2003-06-25
Drug substance claim
No
Drug product claim
No
Assignee
University of Texas System
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.